S&P 500
(0.30%) 4 306.95 points
Dow J
(0.17%) 33 892 points
(0.49%) 13 304 points
(-1.30%) $70.36
(-4.08%) $2.26
(-0.14%) $1 975.90
(0.09%) $24.37
(0.12%) 1 020.60
(0.32%) 0.930
(-1.32%) 10.75
(-0.14%) 0.795
(-0.70%) 81.43

Realtime updates for Yuhan Corporation [000100.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated 9 Jun 2023 @ 02:30
Share On:

-1.15% KRW 60 400

Live Chart Being Loaded With Signals

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally...

Current Price KRW60 400
Today's Volume 165 117
Average Volume 202 406
Market Cap 4 252.31B
P/E 0
ATR14 KRW118.71 (0.19%)

Volume Correlation

Long: 0.51 (weak)
Short: 0.53 (weak)
Signal:(51.901) Neutral

Yuhan Corporation Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuhan Corporation Correlation - Currency/Commodity

The country flag -0.66
( moderate negative )
The country flag -0.66
( moderate negative )
The country flag -0.52
( weak negative )
The country flag -0.53
( weak negative )
The country flag -0.33
( neutral )
The country flag -0.27
( neutral )

Yuhan Corporation Financials

Annual 2022
Revenue: KRW1 775.85B
Gross Profit: KRW518.20B (29.18%)
EPS: KRW1 329.00
Q4 2022
Revenue: KRW450.50B
Gross Profit: KRW136.17B (30.23%)
Q3 2022
Revenue: KRW431.54B
Gross Profit: KRW120.76B (27.98%)
EPS: KRW110.20
Q2 2022
Revenue: KRW482.95B
Gross Profit: KRW145.44B (30.11%)
EPS: KRW499.00

Yuhan Corporation

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; and Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury. The company also provides ETC products, such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems, as well as anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. In addition, it offers over-the-counter (OTC) products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. Further, the company engages in dental business and provides implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and companion animals; and provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators


"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 6.5121731758118 seconds
Number of API calls: 2
Number of DB calls: 7